Phaarmasia Stock Screener | Share Price & Fundamental Analysis
PHRMASI
Pharmaceuticals
Screen Phaarmasia share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹119.50
▲
2.30 (1.96%)
Market Cap
₹71.19 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.73
EPS (TTM)
₹-2.33
Dividend Yield
-
Debt to Equity
0.03
52W High
₹119.50
52W Low
₹24.84
Operating Margin
-4.00%
Profit Margin
2.94%
Revenue (TTM)
₹34.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹22.00
Total Equity
₹9.00
Phaarmasia Share Price History - Stock Screener Chart
Screen PHRMASI historical share price movements with interactive charts. Analyze price trends and patterns.
Phaarmasia Company Profile - Fundamental Screener
Screen Phaarmasia company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PHRMASI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE486I01016
Phaarmasia Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen PHRMASI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 22 | 31 | 28 | 21 | 22 | 34 | 33 | 22 | 20 | 19 |
| Current Assets | 8 | 18 | 15 | 8 | 9 | 20 | 19 | 8 | 6 | 4 |
| Fixed Assets | 12 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 |
| Liabilities | ||||||||||
| Total Liabilities | 22 | 31 | 28 | 21 | 22 | 34 | 33 | 22 | 20 | 19 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 9 | 10 | 11 | 12 | 14 | 13 | 13 | 12 | 12 | 12 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 2 | 4 | 4 | 5 | 7 | 7 | 6 | 5 | 5 | 5 |
Screen PHRMASI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 25 | 31 | 28 | 18 | 21 | 25 | 25 | 21 | 15 | 22 | 19 |
| Expenses | 33 | 26 | 31 | 29 | 19 | 20 | 24 | 24 | 20 | 14 | 21 | 18 |
| EBITDA | 1 | -1 | 0 | -1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | -4.00% | -8.00% | -3.00% | -6.00% | -10.00% | 0.00% | 3.00% | 3.00% | 3.00% | 1.00% | 1.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | -2 | -1 | -1 | -2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | -2 | -1 | -1 | -2 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| EPS | 1.10 | -2.33 | -0.76 | -1.84 | -2.27 | 0.46 | 0.79 | 1.14 | 0.84 | 0.24 | 0.06 | 0.20 |
Phaarmasia Cash Flow Screener - Liquidity Fundamentals
Screen PHRMASI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen PHRMASI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.18% | 25.82% | 25.82% | 26.17% | 26.18% | 26.18% | 26.18% | 26.26% |
| Other Holding | 0.25% | 0.60% | 0.61% | 0.26% | 0.25% | 0.25% | 0.25% | 0.17% |
| Shareholder Count | 20,620 | 20,512 | 20,497 | 20,682 | 20,642 | 20,596 | 20,612 | 20,822 |
Phaarmasia Dividend Screener - Share Yield Analysis
Screen PHRMASI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Phaarmasia Index Membership - Market Screener Classification
Screen PHRMASI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Phaarmasia Market Events Screener - Corporate Actions
Screen PHRMASI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 23.19% | ||
| Annual General Meeting | NA | 17.28% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.94% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -2.44% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.52% |
| 2024-11-05 | 2024-11-05 | Quarterly Result Announcement | NA | 4.89% |
Phaarmasia Competitors Screener - Peer Comparison
Screen PHRMASI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Phaarmasia Company Announcements - News Screener
Screen PHRMASI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th November 2025 To Approve The Unaudited Financial Statement For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Board Meeting Intimation for Notice Of 05Th Board Meeting Of Phaarmasia Limited Scheduled To Be Held On Friday 14Th November 2025 At 05.00 PM(IST). | View |
| 2025-10-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October 2025 | View |
| 2025-10-13 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-10-13 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-09-10 | Announcement under Regulation 30 (LODR)-Restructuring | View |
| 2025-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-03 | Intimation Of 44Th Annual General Meeting Of Phaarmasia Limited And Remote E-Voting. | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-08-13 | Integrated Filing (Financials) For The Quarter Ended 30Th June 2025 | View |